7.09 USD
+0.03 (+0.42%)
7.09 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 84% to LFST. The Buy consensus is the weighted average rating of the current analysts ratings.
LFST was analyzed by 15 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about LFST.
In the previous month the buy percentage consensus was at a similar level.
LFST was analyzed by 15 analysts, which is quite many. So the average rating should be quite meaningful.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-12-12 | BTIG | Maintains | Buy -> Buy |
| 2025-12-09 | Barclays | Initiate | Overweight |
| 2025-11-13 | BMO Capital | Initiate | Outperform |
| 2025-11-07 | UBS | Maintains | Buy -> Buy |
| 2025-11-06 | BTIG | Maintains | Buy -> Buy |
| 2025-08-08 | UBS | Maintains | Buy -> Buy |
| 2025-05-27 | UBS | Upgrade | Neutral -> Buy |
| 2025-04-08 | Keybanc | Initiate | Overweight |
| 2025-04-03 | Canaccord Genuity | Initiate | Buy |
| 2024-12-16 | Goldman Sachs | Upgrade | Neutral -> Buy |
| 2024-11-11 | Barclays | Maintains | Underweight -> Underweight |
| 2024-08-15 | UBS | Maintains | Neutral -> Neutral |
| 2024-08-09 | Barclays | Maintains | Underweight -> Underweight |
| 2024-04-22 | Morgan Stanley | Reiterate | Overweight -> Overweight |
| 2024-03-06 | Jefferies | Maintains | Buy -> Buy |
| 2024-03-04 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2024-02-29 | Barclays | Maintains | Underweight -> Underweight |
| 2023-11-22 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2023-11-17 | JP Morgan | Maintains | Neutral -> Neutral |
| 2023-08-10 | JP Morgan | Maintains | Neutral -> Neutral |
| 2023-07-13 | Morgan Stanley | Reiterate | Overweight -> Overweight |
| 2023-05-19 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2023-05-11 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2023-01-06 | Morgan Stanley | Upgrade | Equal-Weight -> Overweight |
| 2022-11-15 | Goldman Sachs | Maintains | Neutral |
| 2022-11-14 | Cowen & Co. | Maintains | Outperform |
| 2022-08-22 | Cowen & Co. | Maintains | Outperform |
| 2022-05-10 | Morgan Stanley | Maintains | Equal-Weight |
| 2021-12-17 | Morgan Stanley | Maintains | Equal-Weight |
| 2021-11-09 | JP Morgan | Downgrade | Overweight -> Neutral |
LIFESTANCE HEALTH GROUP INC / LFST FAQ
Can you provide the consensus rating for LIFESTANCE HEALTH GROUP INC stock?
The consensus rating for LIFESTANCE HEALTH GROUP INC (LFST) is 84 / 100 . This indicates that analysts generally have a positive outlook on the stock.